EIF2AK2 and Alzheimer disease: Consistent with this outcome, tau protein modified at sites phosphorylated by PKR accumulates in tauopathies, AD and in other neurodegenerative diseases (Cavallini et al., 2013; Sossin and Costa-Mattioli, 2019; Reimer et al., 2021; Martinez et al., 2021).